Clinical Trial Update: Drug-eluting-stents for Unprotected Left Main Stem Disease (ISAR-LEFT-MAIN) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on drug-eluting stents for unprotected left main coronary artery disease; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: Deutsches Herzzentrum Muenchen | Conditions: Coronary Disease | Phase 4 | Status: COMPLETED